MoneyWorks4Me

Unjha Formulations - Quaterly Results

04 Aug 2023 Evaluate
The turnover for the June 2023 quarter moved up 51.19% to Rs. 37.60 millions as compared to Rs. 24.87 millions during the year-ago period.The Total revenue for the quarter ended June 2023 of  Rs. 1.82  millions  grew by 313.64% from Rs. 0.44 millions.The company reported a good operating profit of 2.05 millions compared to 0.65 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 37.60 24.87 51.19 37.60 24.87 51.19 131.84 143.51 -8.13
Other Income -0.06 0.01 -700.00 -0.06 0.01 -700.00 0.00 0.00 0.00
PBIDT 2.05 0.65 215.38 2.05 0.65 215.38 4.63 5.09 -9.04
Interest 0.19 0.01 1800.00 0.19 0.01 1800.00 0.58 1.32 -56.06
PBDT 1.86 0.64 190.62 1.86 0.64 190.62 4.05 3.77 7.43
Depreciation 0.04 0.20 -80.00 0.04 0.20 -80.00 0.77 0.76 1.32
PBT 1.82 0.44 313.64 1.82 0.44 313.64 3.28 3.01 8.97
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.47 0.47 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1.82 0.44 313.64 1.82 0.44 313.64 2.81 2.54 10.63
Equity 44.81 44.81 0.00 44.81 44.81 0.00 44.81 44.81 0.00
PBIDTM(%) 5.45 2.61 108.60 5.45 2.61 108.60 3.51 3.55 -0.99
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..